JavaScript NENÍ povolen !

Prosím povolte JavaScript.

* Zobrazit nápovědu

Reset

Pracoviště: Oncogeriatric Unit Department of Geriatric Medi...

1 záznamů v Medvik Filtry

Článek

Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab

Langerak, A. W., 1967-
Autor Autorita ORCID Department of Immunology, Laboratory for Medical Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands
Ritgen, Matthias
Autor Ritgen, Matthias Department of Hematology, University of Schleswig-Holstein, Kiel, Germany
Goede, Valentin
Autor Goede, Valentin Oncogeriatric Unit, Department of Geriatric Medicine, St. Marien Hospital, Cologne, Germany. German CLL Study Group, Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital of Cologne, Cologne, Germany
Robrecht, Sandra
Autor Robrecht, Sandra German CLL Study Group, Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital of Cologne, Cologne, Germany
Bahlo, Jasmin
Autor Bahlo, Jasmin German CLL Study Group, Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital of Cologne, Cologne, Germany
Fischer, Kirsten
Autor Fischer, Kirsten German CLL Study Group, Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital of Cologne, Cologne, Germany
Steurer, Michael
Autor Steurer, Michael Division of Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria
Trněný, Marek
Autor Trněný, Marek Charles University Hospital, Prague, Czech Republic
Mulligan, Stephen P
Autor Mulligan, Stephen P Royal North Shore Hospital, University of Sydney, Sydney, Australia
Mey, Ulrich J M
Autor Mey, Ulrich J M Kantonsspital Graubünden, Chur, Switzerland

Blood. 2019 ; 133 (5) : 494-497. [pub] 20181119

ISSN 1528-0020
Medvik
Zdroj

Kolekce

Publikováno

Filtry

Filtry

* Zobrazit nápovědu

* Zobrazit nápovědu

Upřesnit dle MeSH